PT-141 research: quick summary
PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist studied in controlled research settings. This Canadian product listing concerns laboratory research material only. It is not an authorized medicine, does not provide dosing or administration instructions, and is not intended for human or veterinary use.
PT-141 Canada: PT-141 10mg Research Product
PT-141 Canada researchers can order PT-141 10mg directly from Red Leaf Research Labs. This listing supplies a single 10mg vial of lyophilized PT-141 for qualified laboratory use, with published analytical information, Canadian-dollar pricing and domestic express fulfilment.
For searches such as buy PT-141 Canada, bremelanotide Canada or PT-141 peptide Canada, the practical questions are the same ones that apply to any research peptide: what is in the vial, who tested it, when it was tested, and whether the buyer is authorized to obtain research-use material. This page answers those questions rather than describing outcomes.
Red Leaf Research Labs supplies research material to qualified purchasers in Canada. Nothing on this page describes a therapy, a treatment or a permitted personal use.
PT-141 10mg Research Format and Options
| Attribute | Detail |
|---|
| Research format | PT-141 10mg, single vial |
| Physical state | Lyophilized powder |
| Analytical documentation | Third-party report available for the current lot |
| Fulfilment | Domestic Canadian express shipping |
| Intended use | Qualified laboratory research only |
PT-141 is listed as a single research quantity rather than a range. Laboratories comparing this listing with multi-size offerings elsewhere should confirm that the compared vials carry equivalent analytical documentation before treating them as equivalent material.
PT-141 Research Specifications
- Compound name: PT-141
- Alternative name: Bremelanotide
- Research shorthand: PT 141; PT-141 10mg for this research option
- Peptide class: Cyclic heptapeptide melanocortin receptor agonist
- Receptor interest: Studied at melanocortin receptors, with MC3R and MC4R the usual focus in published work
- Structural origin: Analogue derived from the alpha-melanocyte-stimulating hormone family; a metabolite of melanotan II
- CAS number: 189691-06-3
- Molecular formula: C50H68N14O10
- Molecular weight: Approximately 1025.2 g/mol
- Physical format: Lyophilized powder
- Available research quantity: 10mg
- Intended use: Qualified laboratory research only
- Fulfilment: Domestic Canadian express shipping
What Is PT-141?
PT-141 is a synthetic cyclic peptide developed from the melanocortin family. Where many research peptides in the Canadian market are studied for metabolic or repair-related signalling, PT-141 is studied for its activity at melanocortin receptors in the central nervous system, which places it in a different research category from the GLP-1 and growth-factor compounds it often sits beside on a supplier’s catalogue.
The compound is structurally related to melanotan II and arose from work on that molecule. That relationship is frequently misstated in vendor listings: PT-141 and melanotan II are distinct compounds with distinct receptor profiles and distinct analytical signatures, and a certificate of analysis for one does not describe the other.
PT-141 and Melanocortin Receptor Research
Melanocortin receptors are a family of G-protein-coupled receptors distributed across the central nervous system and peripheral tissue. Published research on PT-141 has concentrated on receptor-level activity rather than on downstream vascular mechanisms, which distinguishes it from earlier compound classes studied in related contexts.
Research findings in this area are protocol-specific. Receptor affinity measured in a laboratory model does not establish a safety profile, an effect size, or an appropriate use in any person. Qualified laboratories designing work with PT-141 should treat published receptor data as a starting point for their own controlled study design, not as a description of what the material does outside that setting.
Why Buy PT-141 10mg in Canada from a Domestic Research Supplier?
PT-141 is a small cyclic peptide and is not the most fragile thing in a shipping box, but transit still matters. Every extra week in an uncontrolled environment is a week of accumulated heat and humidity exposure that no certificate issued before shipping can account for.
The larger argument for domestic supply is accountability. An order that goes wrong with an offshore reseller has no practical remedy; an order that goes wrong with a Canadian business does. That difference tends to matter more than the shipping time itself.
How This PT-141 Canada Page Improves on Typical Competitor Listings
Most PT-141 listings in this market share the same weaknesses. This page is built to avoid them:
- Compound-specific copy. The description on this page concerns PT-141 and no other compound. Generic boilerplate reused across a catalogue tells a researcher nothing.
- Stated analytical basis. Purity is presented as a measured result tied to a lot and a method, not as an unsourced percentage in a headline.
- No outcome claims. This listing does not describe experiences, results or benefits, because a research-use listing is not the place for them.
- Explicit regulatory framing. The relationship between research supply and approved medicines is stated plainly below rather than left ambiguous.
- Named structural relationships. The melanotan II relationship is stated rather than glossed over, so a laboratory can plan its identity testing accordingly.
How to Evaluate a PT-141 Certificate of Analysis
Because PT-141 sits structurally close to melanotan II, identity is the check that carries the most weight on this compound. Work through the report in this order:
- Named molecule: the report should say PT-141 or bremelanotide — not melanotan II, not “melanocortin peptide”.
- Mass confirmation: around 1025 daltons for the free peptide; a figure materially off that is a different molecule.
- Lot reference: cross-check the identifier against what is on the vial you receive.
- Date of analysis: a report predating the lot it is attached to describes nothing.
- Method: note which technique produced the purity number and what it is blind to.
- Reported quantity: should reconcile with the 10mg format.
- Independent check: the report should carry a reference you can verify with the issuing laboratory.
Red Leaf publishes Janoshik reports with a verification key. A purity figure you cannot trace back to a testing laboratory is a marketing number, whatever it says.
PT-141 10mg Lyophilized Research Format
The 10mg vial arrives as a lyophilized cake. Lyophilization is a drying process, not a purification step, and not a guarantee: it tells you the material was freeze-dried, not that it is what the label says or that it survived the trip.
Cyclic peptides such as PT-141 are relatively robust in the dry state, but the ring structure is not indefinitely stable in solution. Once reconstituted, storage duration becomes a variable in its own right. Inspect the cake on arrival, tie the vial to its analytical report, and follow your institution’s validated procedures. Background on diluent choice is in bacteriostatic water uses and handling.
How to Buy PT-141 in Canada for Qualified Research
- Establish eligibility. Confirm the purchaser and institution are authorized to hold research-use material.
- Read the report first. Check it names PT-141 or bremelanotide before you order, not after the vial arrives.
- Plan identity testing. If your work depends on distinguishing PT-141 from melanotan II, decide how you will confirm that in-house.
- Confirm the destination. Somewhere able to receive and store the material the day it lands.
- Log it in. Lot reference, arrival condition, storage location, against the study plan.
Fulfilment is to qualified Canadian purchasers by domestic express. Red Leaf supplies material and documentation; it does not advise on study design and provides nothing that supports use in humans or animals.
PT-141 Availability in Canada: Research vs. Consumer Searches
Searches for PT-141 in Canada come from two very different places, and conflating them causes real problems.
A bremelanotide-based medicine has been approved in some jurisdictions outside Canada under a pharmaceutical brand name, prescribed and dispensed under regulatory control. That approved medicine is a different thing from research material: different manufacturing regime, different documentation, different legal category, and different accountability. Research-use PT-141 is not that product and is not a substitute for it.
Research supply and public medical availability are separate categories. A vial available to a qualified laboratory is not an approved retail medicine, a pharmacy product, or a substitute for professional care. Anyone searching from a personal health motivation should speak with a licensed clinician rather than a research supplier.
PT-141 10mg Canada Procurement Checklist
| Check | What to confirm |
|---|
| Purpose | Authorized laboratory research with an approved study plan |
| Identity | PT-141 / bremelanotide name, CAS 189691-06-3 and the relevant analytical method |
| Distinctness | Documentation identifies PT-141 rather than melanotan II |
| Quantity | PT-141 10mg research format |
| Documentation | Current sample or lot reference, test date, measured amount and purity result |
| Verification | Report can be checked against the issuing laboratory |
| Handling | Storage and preparation procedures validated by the receiving institution |
Explore PT-141 Research Information
For a broader view of how compounds in this category are studied and where the evidence stops, see peptides studied in potency and sexual-function research. For supplier-selection criteria in the Canadian market, review how to evaluate a Canadian research peptide supplier. For handling context that applies to every lyophilized vial, see bacteriostatic water uses and handling.
PT-141 research FAQ
What is PT-141 studied for?
Published work examines its activity at melanocortin receptors, principally MC3R and MC4R, within defined laboratory models. Receptor activity in a model does not establish an effect in any person.
Is PT-141 the same as melanotan II?
No. PT-141 is structurally related to melanotan II and arose from research on it, but they are distinct compounds with distinct receptor profiles. Analytical documentation for one does not describe the other.
Does an approval in another country make this vial a medicine?
No. An approved pharmaceutical product manufactured, documented and dispensed under regulatory control is a different category from research-use material, regardless of shared chemistry.
What should Canadian laboratories verify before ordering?
Confirm intended use, batch identity, analytical documentation, storage requirements and institutional approval before purchase, and confirm the report identifies PT-141 specifically.
Does Red Leaf Research Labs provide dosing information?
No. Red Leaf Research Labs supplies research material and analytical documentation only, and does not provide dosing, protocols or any guidance supporting use in humans or animals.
Research use only. PT-141 supplied by Red Leaf Research Labs is intended for qualified laboratory research. It is not a medicine, not for human or veterinary use, and not for diagnostic or therapeutic application.
Owned and operated by a cf veteran 
